GeneThera, Inc. announced that it has entered into an exclusive agreement with Cushman & Wakefield to identify land sites and warehouse buildings in the Denver area in connection with the development of GeneThera Zoonotic Disease Alert Shield (ZIDAS) surveillance network. While the Stationary BSL3 laboratory is built, the Company operation will be primarily focused on the assembly of the Mobile Laboratory Units (MLU) as part of the ZIDAS surveillance system network. Cushman & Wakefield's initial objective is to identify warehouse spaces where the MLU will be assembled and stored.

Colorado will be the first site of a network that will span throughout the US and will continue to grow over the next several years; domestically and internationally.